Hydroxymethylglutaryl-CoA Reductase Inhibitors: Clinical Trials

191 trials of Hydroxymethylglutaryl-CoA Reductase Inhibitors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

100 completed, 40 unknown, 20 recruiting, 16 terminated. 48 Phase 4, 37 Phase 2, 32 Not applicable, 28 Phase 3, 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 448Completed 22, Unknown 13, Terminated 5, Not yet recruiting 3, Recruiting 3, Active not recruiting 1, Withdrawn 1
Phase 237Completed 19, Unknown 11, Terminated 4, Recruiting 3
Not applicable32Completed 15, Unknown 7, Not yet recruiting 3, Recruiting 2, Terminated 2, Withdrawn 2, Active not recruiting 1
Phase 328Completed 17, Unknown 6, Recruiting 3, Terminated 2
Phase 15Completed 2, Recruiting 1, Terminated 1, Unknown 1
Early Phase 12Completed 1, Unknown 1

Follow Hydroxymethylglutaryl-CoA Reductase Inhibitors: new trials by email Literature Review of Hydroxymethylglutaryl-CoA Reductase Inhibitors trials Research Report on Hydroxymethylglutaryl-CoA Reductase Inhibitors

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma
Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran) - Melanoma
Not applicableRecruitingUniversity of Colorado, Denver402026-10-192026-10-22
Effects of Short-term Intensive Statin Therapy on Lipid Levels
statin - Ischemic Stroke
RecruitingGeneral Hospital of Shenyang Military Region8002026-01-082026-01-15
COAST Study - Cholesterol Optimization After Stroke
low-fat diet, supplements, statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, fibrates, or other lipid-lowering agents - Stroke (CVA) or Transient Ischemic Attack, Cerebral Hemorrhage
Not yet recruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS5002026-01-012025-12-01
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
Tofacitinib 5 MG - Rheumatoid Arthritis, Major Adverse Cardiac Events
Phase 4RecruitingShaikh Zayed Hospital, Lahore1202025-12-062026-04-28
PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis
Recaticimab and Statin, Statin - Intracranial Atherosclerosis, Intracranial Artery Stenosis
Phase 4RecruitingPeking Union Medical College Hospital3002025-11-072026-06-12
Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease
Pioglitazone (PIO), Empagliflozin, Statin (Atorvastatin) - Non-alcoholic Fatty Liver Disease NAFLD, Non-alcoholic Steatohepatitis NASH
Phase 4Not yet recruitingBadr University4002025-11-012025-09-18
Effects of Statins and Hormone Replacement Therapy in Coagulation Profile of Menopausal Women With Dyslipidemia
estroprogestins, Statin - Menopausal Complaints, Hypercholerolemia
RecruitingUniversity of Pisa702025-10-152026-08-03
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
statin + ezetimibe, Statin monotherapy (rosuvastatin or atorvastatin) - Ischemic Stroke, Hypercholesteremia
Phase 2RecruitingChang Gung Memorial Hospital3002025-08-012025-12-30
Randomized Comparison of Morning Versus Bedtime Administration of Statins: A Cardiovascular Circadian Chronotherapy (C3) Trial
Statin in the evening (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin), Statin in the morning (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin) - Cardiovascular Diseases (CVD), Drug Effect
Phase 4Not yet recruitingTor Biering-Sørensen420002025-02-282025-03-04
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
Statin (atorvastatin, fluvastatin, pravastatin, rosuvastatin or simvastatin) - Ischemic Stroke, Transient Ischemic Attack
Phase 4Not yet recruitingProf. dr. Nathalie van der Velde6122025-02-012025-01-21
Protective Effect of PCSK9 Inhibitor Against Negative Inflammatory Response and Organ Dysfunction After Coronary Artery Bypass Grafting (PANDA VIII)
PCSK9 inhibitor, Statin - Myocardial Ischaemic Syndrome, Coronary Heart Disease
Not applicableNot yet recruitingNanjing Medical University4002025-01-012024-12-12
Multicenter Real-World Cohort Study Evaluating the Impact of Early Intensive Lipid-Lowering Therapy on the Prognosis of Acute Coronary Syndrome Patients(ELITE-ACS)
PCSK9 inhibitor, Statin+Ezetimibe/Hybutimibe compound, Statin - Acute Coronary Syndromes
RecruitingYun Dai Chen60002024-12-162025-03-17
Statins in Frail Older Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Statin - Ischemic Stroke, TIA
RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3002024-11-012025-01-21
Chronic Coronary Syndrome Real Practice and Guidelines
Statins (atorvastatin or simvastatin) - Coronary Arterial Disease (CAD)
Active not recruitingAssiut University3002024-10-222024-11-12
Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke
Statin, Probucol - Ischemic Stroke, Atherosclerosis of Artery
RecruitingXuanwu Hospital, Beijing2002024-10-172025-03-25
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Statin - Solid Tumors, Ototoxicity
Phase 1 / Phase 2CompletedMinia University562024-09-012026-01-20
Effect of SLC01B1 (rs4149956) Polymorphism on the Efficacy and Tolerability of Atorvastatin in Pakistani Population
Atorvastatin - Hyperlipidemias
CompletedRiphah International University1502024-09-012025-08-29
Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial
Statin (rosuvastatin 10 or 40 mg daily, depending on risk), Healthy Lifestyle Counseling, Outpatient Followup - Lipid Disorder, Hypercholesterolemia
Phase 2RecruitingWake Forest University Health Sciences1302024-08-052026-02-27
Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography
PCSK9 inhibitor, Statin - Coronary Artery Disease, Optical Coherence Tomography
Phase 4RecruitingFirst Affiliated Hospital of Xinjiang Medical University3962024-07-012024-08-19
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer
Statin, Sugar pill - Ovarian Cancer
Phase 2UnknownAnhui Provincial Cancer Hospital5002024-06-302024-06-21

Showing 20 of 191. Sign in to see all of them.

Conditions studied

Hypercholesterolemia (25)  ·  Dyslipidemias (19)  ·  Atherosclerosis (15)  ·  Cardiovascular Diseases (14)  ·  Ischemic Stroke (13)  ·  Coronary Artery Disease (12)  ·  Hypertension (10)  ·  Myocardial Infarction (10)  ·  Coronary Disease (9)  ·  Hyperlipidemias (9)  ·  Acute Coronary Syndrome (8)  ·  Stroke (8)  ·  Diabetes Mellitus (6)  ·  Diabetes Mellitus, Type 2 (6)  ·  COVID-19 (4)

Sponsors

Organon and Co (7)  ·  Yonsei University (5)  ·  Columbia University (3)  ·  Gachon University Gil Medical Center (3)  ·  Peking Union Medical College Hospital (3)  ·  University of Sao Paulo General Hospital (3)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Assiut University (2)  ·  Beijing Anzhen Hospital (2)  ·  Beth Israel Deaconess Medical Center (2)  ·  Chang Gung Memorial Hospital (2)  ·  Eli Lilly and Company (2)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (2)  ·  Mario Negri Institute for Pharmacological Research (2)  ·  NYU Langone Health (2)

Countries

United States (36)  ·  China (26)  ·  South Korea (13)  ·  Canada (12)  ·  Italy (11)  ·  Egypt (10)  ·  Brazil (8)  ·  United Kingdom (8)  ·  Germany (7)  ·  Spain (6)  ·  Taiwan (6)  ·  Japan (5)  ·  Netherlands (5)  ·  Norway (5)  ·  Australia (4)

Top investigators

Andria Priyana, MD, FIHA (2)  ·  Angela F Sunjaya (2)  ·  Anthony P Sunjaya (2)  ·  Jeffrey Berger, MD (2)  ·  Masayasu Matsumoto, MD, PhD (2)  ·  Nathalie van der Velde, Prof. dr. (2)  ·  Sanja Jelic, MD (2)  ·  Yong Huo, MD (2)  ·  Aflak Rasheed, FCPS (1)  ·  Ahmed Abdel-Galeel, MD (1)  ·  Ahmed F Mahmoud Hussein, MS.c (1)  ·  Ahmed HM El-Abd, Msc (1)  ·  Andreas Birkenfeld, MD, PhD (1)

Results publications

PMID 28304224, PMID 10205010, PMID 10323786, PMID 11009277, PMID 11558482, PMID 11849859, PMID 12379573, PMID 12423708, PMID 12652104, PMID 15811480, PMID 16579514, PMID 17452537, PMID 17548554, PMID 17548555, PMID 17804683, PMID 17936040, PMID 17975198, PMID 18347202, PMID 18404599, PMID 18413499, PMID 18452788, PMID 18539753, PMID 18584016, PMID 18587715, PMID 19060422, PMID 19101028, PMID 19249441, PMID 19538732, PMID 19967051, PMID 20204386, PMID 20298928, PMID 20529243, PMID 21543628, PMID 21689398, PMID 21899409, PMID 22089718, PMID 22166847, PMID 22237748, PMID 22291820, PMID 22416821, PMID 22440219, PMID 22621316, PMID 22723583, PMID 22831708, PMID 22997344, PMID 23040716, PMID 23085245, PMID 23583255, PMID 23600368, PMID 24161333

NIH funding

2015 (3), R01HL106041 (2), 2005 (1), 2023 (1), K23HL169929 (1), R01CA218486 (1), R34HL143279 (1)